Cargando…

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients

BACKGROUND: The 3'UTR region plays a crucial role in regulating gene expression at posttranscriptional levels. Any changes in sequence in this region can cause numerous pathologies and can also lead to tumour development. The most common changes reported in in the CDKN2A gene are the 148Ala/Thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Przybyła, Anna, Lamperska, Katarzyna, Mackiewicz, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631302/ https://www.ncbi.nlm.nih.gov/pubmed/26557774 http://dx.doi.org/10.5114/wo.2015.54227

Ejemplares similares

The mystery of let-7d – a small RNA with great power
por: Kolenda, Tomasz, et al.
Publicado: (2014)

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population
por: Mackiewicz-Wysocka, Małgorzata, et al.
Publicado: (2017)

Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development
por: Bruno, William, et al.
Publicado: (2017)

Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome
por: Sobocińska, Joanna, et al.
Publicado: (2020)

A variant in SIRT2 gene 3′-UTR is associated with susceptibility to colorectal cancer
por: Yang, Yong, et al.
Publicado: (2017)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

2D and 3D cell cultures – a comparison of different types of cancer cell cultures
por: Kapałczyńska, Marta, et al.
Publicado: (2016)

Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization
por: Przybyla, Anna, et al.
Publicado: (2021)

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines
por: Guglas, Kacper, et al.
Publicado: (2018)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
por: Kwiatkowska-Borowczyk, Eliza, et al.
Publicado: (2018)

Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma
por: Mackiewicz, Jacek, et al.
Publicado: (2017)

Recent advances in melanoma treatment – American Society of Clinical Oncology (ASCO) 2012 perspective
por: Mackiewicz, Jacek, et al.
Publicado: (2012)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
por: Kopczyńska, Magda, et al.
Publicado: (2020)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma.
por: Platz, A., et al.
Publicado: (1996)

Significance of CDKN2A gene A148T variant in patients with bladder cancer
por: Borkowska, Edyta, et al.
Publicado: (2011)

Tandem RNA isolation reveals functional rearrangement of RNA-binding proteins on CDKN1B/p27(Kip1) 3’UTRs in cisplatin treated cells
por: Iadevaia, Valentina, et al.
Publicado: (2019)

Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer
por: Puig-Butille, Joan Anton, et al.
Publicado: (2013)

Surveillance, CDKN2A and survival of familial melanoma
por: van Doorn, Remco
Publicado: (2023)

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

lncRNA in HNSCC: challenges and potential
por: Guglas, Kacper, et al.
Publicado: (2017)

Bioinformatics Analysis Revealed Novel 3′UTR Variants Associated with Intellectual Disability
por: Yang, Junmeng, et al.
Publicado: (2020)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

A highly recurrent RPS27 5'UTR mutation in melanoma
por: Dutton-Regester, Ken, et al.
Publicado: (2014)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

The A148T variant of CDKN2A gene in bladder cancer
por: Borkowska, E, et al.
Publicado: (2011)

The Impact of 3′UTR Variants on Differential Expression of Candidate Cancer Susceptibility Genes
por: Skeeles, Laura E., et al.
Publicado: (2013)

Translational control by 3′-UTR-binding proteins
por: Szostak, Emilia, et al.
Publicado: (2013)

Regulatory features aid interpretation of 3’UTR Variants
por: Romo, Lindsay, et al.
Publicado: (2023)

Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment
por: Zaleska, Karolina, et al.
Publicado: (2017)

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts
por: Xie, Huaping, et al.
Publicado: (2016)

Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants
por: Overbeek, Kasper A, et al.
Publicado: (2021)

A Variant in a MicroRNA Complementary Site in the 3′UTR of the KIT Oncogene Increases Risk of Acral Melanoma
por: Godshalk, Sirie E., et al.
Publicado: (2010)

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families
por: Potjer, Thomas P., et al.
Publicado: (2019)

Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins
por: Barrett, J H, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_hgohesfel3fadj0kaf7qi3k6d2